Associations of impaired behaviors with elevated plasma chemokines in autism spectrum disorders - Wikidata - awgldk - TriplyDB

Associations of impaired behaviors with elevated plasma chemokines in autism spectrum disorders

Associations of impaired behaviors with elevated plasma chemokines in autism spectrum disorders

http://www.wikidata.org/entity/Q34645392

about

Maternal infection and immune involvement in autism The role of immune dysfunction in the pathophysiology of autism Maternal and fetal antibrain antibodies in development and disease A Non-inflammatory Role for Microglia in Autism Spectrum Disorders Consensus paper: pathological role of the cerebellum in autism Maternal high fat diet consumption during the perinatal period programs offspring behavior Inflammatory cytokines: potential biomarkers of immunologic dysfunction in autism spectrum disorders Common Genetic Variants Found in HLA and KIR Immune Genes in Autism Spectrum Disorder Developmental neurotoxicity of inhaled ambient ultrafine particle air pollution: Parallels with neuropathological and behavioral features of autism and other neurodevelopmental disorders In utero exposure to toxic air pollutants and risk of childhood autism Gender-dependent effects of maternal immune activation on the behavior of mouse offspring In search of cellular immunophenotypes in the blood of children with autism An Overview of Autism Spectrum Disorder, Heterogeneity and Treatment Options.Maternal Immune Activation Causes Behavioral Impairments and Altered Cerebellar Cytokine and Synaptic Protein Expression Interactions of innate and adaptive immunity in brain development and function.Dietary supplementation with n-3 fatty acids from weaning limits brain biochemistry and behavioural changes elicited by prenatal exposure to maternal inflammation in the mouse model.Behavioral alterations in rat offspring following maternal immune activation and ELR-CXC chemokine receptor antagonism during pregnancy: implications for neurodevelopmental psychiatric disorders Maternal immune activation causes age- and region-specific changes in brain cytokines in offspring throughout development.The immune system and developmental programming of brain and behavior.Myeloid dendritic cells frequencies are increased in children with autism spectrum disorder and associated with amygdala volume and repetitive behaviors.Clinical report of a 17q12 microdeletion with additionally unreported clinical features.Risk factors in autism: Thinking outside the brain.Neonatal cytokines and chemokines and risk of Autism Spectrum Disorder: the Early Markers for Autism (EMA) study: a case-control study Unraveling the mechanisms responsible for the comorbidity between metabolic syndrome and mental health disorders.Levels of soluble platelet endothelial cell adhesion molecule-1 and P-selectin are decreased in children with autism spectrum disorder.Emerging Roles for the Gut Microbiome in Autism Spectrum Disorder.Change in plasma cytokine levels during risperidone treatment in children with autism Molecular basis of lateral force spectroscopy nano-diagnostics: computational unbinding of autism related chemokine MCP-1 from IgG antibody LPS elicits a much larger and broader inflammatory response than Escherichia coli infection within the hippocampus of neonatal rats.Maternal immune activation leads to activated inflammatory macrophages in offspring The major histocompatibility complex and autism spectrum disorder.The possible link between elevated serum levels of epithelial cell-derived neutrophil-activating peptide-78 (ENA-78/CXCL5) and autoimmunity in autistic children.Immune mediated conditions in autism spectrum disorders.The Impact of Maternal High-Fat Diet Consumption on Neural Development and Behavior of Offspring The role of maternal obesity in the risk of neuropsychiatric disorders.Increased production of IL-17 in children with autism spectrum disorders and co-morbid asthma.Sex, glia, and development: interactions in health and disease.HLA Immune Function Genes in Autism.Maternal high-fat diet programming of the neuroendocrine system and behavior Major histocompatibility complex class I proteins in brain development and plasticity.

P2860

Q22252357-7B66A892-0757-4EAE-B266-BBE77597D267 Q22252518-6413E40A-E2E0-4789-9F41-85727D3E15B8 Q24625610-2E51EAA5-C38C-4379-859A-3004906CE5B5 Q26766460-F0E2AD60-825D-4EBC-B5F8-796B4CFB375D Q26830626-D2206845-7C01-441A-85DE-5F10FBF13DA7 Q26849202-ED2BF996-1372-472D-8B8A-8CF059090B5D Q27003260-52A76C68-70E2-48BD-96EE-3059E6C90877 Q28066081-8B575066-0469-4C45-8D83-1C2ED329FFF6 Q28397524-0C49B12C-79C9-43E4-9538-B97166329761 Q28397994-E961CA4B-CAF1-439B-BFA7-CFDDAAC25A1E Q28541767-15C9B9C7-5E02-40CF-B4B2-0ABC38F58BFF Q28740461-095B796F-6DB5-47F3-BA7A-4A693D43C504 Q30235878-1C526E3F-3240-400A-8AF4-98257F4389AB Q30355368-4DBF792B-4F95-478D-8921-B47637D90B73 Q30357060-682A6F35-CC1B-4C69-BAF4-AC0E0ABFF5B5 Q30372082-FC6D0AD8-FB99-46D0-9BB5-DFA69238AEB3 Q30389278-DFB4AC7E-8565-470E-AC67-E1B33BCFFCF3 Q30435550-484F7B88-5210-46A0-A1DD-CB7E461CAA4F Q30449556-96A56819-8FAA-42D4-B59E-7E7C2E8BCEC9 Q30573268-4566EFFD-0DA7-4954-ABC9-3904EF69715A Q33765966-5E532A5C-95DF-41F5-BFF0-928FDCE0CF96 Q33788661-4F8F1B47-5EC1-4FDA-A1CC-C32C9028E086 Q33840900-92AC5C12-FA07-4C1D-ABE5-11ED9CA44BF7 Q34000520-1A2773FF-6BD2-4955-812B-C60294B71F11 Q34282952-A8788B99-D9FC-4A53-BAD1-3E059798BDA4 Q34679392-902D49D8-9F28-41D3-A7AC-33BD2B794B2E Q34719440-D1176CAE-47AA-406B-AF24-2C6B85AB3BD5 Q34995989-59717975-1EFA-418B-88B6-29B8E91352C3 Q35011957-D001A23B-AA78-45EA-873E-252F3EEC776D Q35064112-F91E4E41-ABC4-4FD0-B27A-7B92A47AE805 Q35193880-5FA305BE-E905-4DA0-98A2-2B69C28FDE0E Q35222567-5FCD3CDB-720D-4D80-937F-307B4468AA6B Q35554314-50B2F184-50A9-4408-950C-2A1D5F1E7EF1 Q35701480-48C21DD2-E4F4-4368-963D-2EB550E2CB3C Q35753339-9EFCA9F0-015E-4FDF-BA16-2398A6A04904 Q35994564-4D34808A-10E8-4D19-8615-EE6AAEF7E65E Q36028386-6DF236DC-B595-459E-86C0-161535A4CA6C Q36169472-86C96472-EAF2-419D-9687-905AA65DAA9E Q36202814-289A44DB-FE46-4990-8FFC-002570B441B7 Q36384439-B6D52C60-17C1-44C4-8249-D97186FDA664

P2860

Associations of impaired behaviors with elevated plasma chemokines in autism spectrum disorders

http://www.wikidata.org/entity/Q34645392

description

2010 nî lūn-bûn

@nan

2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Associations of impaired behav ...... s in autism spectrum disorders

@ast

Associations of impaired behav ...... s in autism spectrum disorders

@en

Associations of impaired behav ...... s in autism spectrum disorders

@nl

type

label

Associations of impaired behav ...... s in autism spectrum disorders

@ast

Associations of impaired behav ...... s in autism spectrum disorders

@en

Associations of impaired behav ...... s in autism spectrum disorders

@nl

prefLabel

Associations of impaired behav ...... s in autism spectrum disorders

@ast

Associations of impaired behav ...... s in autism spectrum disorders

@en

Associations of impaired behav ...... s in autism spectrum disorders

@nl

P1433

Q34645392-03EE81AB-2E27-46E4-9ACE-5B771E3BE76A

P1476

Q34645392-066BE965-4E4D-4436-A403-303A758A486A

P2093

Q34645392-1210E402-C681-48C6-9F7D-64C30A92CC74

Q34645392-6DCC4D54-D40D-413C-A5AE-F881329C4486

Q34645392-7DFB5CFF-E662-4D50-90B5-E3923B7BED14

Q34645392-A9301B65-8CDB-4A1B-9543-ABC7613348D7

Q34645392-E7DE6C35-29CD-47E0-AA7C-D490E45B1E76

P2860

Q34645392-10D630C4-2056-4C2B-9589-666EFCF5B4C8

Q34645392-1639B4B7-8918-4BBA-9357-FE478CCA3F6F

Q34645392-22391661-5AC5-46DD-9A74-3EE36F774624

Q34645392-24DD1B99-D0AB-420E-82D2-4D7122AE811E

Q34645392-2F91FAE0-914E-40C7-990C-031BAAEF4180

Q34645392-3666CE16-528D-4E76-B9D5-AC89EC3BAB75

Q34645392-49432BB0-C42F-4FBA-9A65-2A4C1ED9CB2D

Q34645392-4ED0718D-770D-4A21-81D2-1790987853C4

Q34645392-5FE9EA08-B62C-416E-B7E5-9D24133DF68B

Q34645392-64B7D374-7A0E-4487-A058-0C072645F27C

P304

Q34645392-9B050139-29EF-45D1-ACCB-50A1A7C712F0

P31

Q34645392-0F1C6F96-FA1C-4388-987B-2DD1FF636716

P356

Q34645392-1C144BE2-8741-4C12-82DE-30C2BC988DCF

P433

Q34645392-2218D44A-A7D8-4338-8A76-C095AB1B727C

P478

Q34645392-52EC8E9D-CB9E-4B98-834E-C7C9854E6AEA

P50

Q34645392-54E90CDB-CEBE-4011-8665-6D4EDF8C8A32

P577

Q34645392-A70553DF-523C-4BD8-9D6E-11FF9D476324

P5875

Q34645392-F573B329-EBE3-47D0-9225-31EC5BF2F8AF

P698

Q34645392-93559102-D96D-4072-BEC2-9B6B4AFE8EB9

P921

Q34645392-68E059DD-689A-4CE5-AA1E-00BE378D367D

Q34645392-9785D49E-B49D-4F66-9DF1-3835A901238B

P932

Q34645392-0F0F5012-955A-447F-9ECB-BD19E08F78FA

P356

J.JNEUROIM.2010.10.025

P1433

Journal of Neuroimmunology

P1476

Associations of impaired behav ...... s in autism spectrum disorders

@en

P2093

Isaac N Pessah

http://www.w3.org/2001/XMLSchema#string

Judy Van de Water

http://www.w3.org/2001/XMLSchema#string

Paul Ashwood

http://www.w3.org/2001/XMLSchema#string

Paula Krakowiak

http://www.w3.org/2001/XMLSchema#string

Robin Hansen

http://www.w3.org/2001/XMLSchema#string

P2860

The CHARGE study: an epidemiologic investigation of genetic and environmental factors contributing to autism

Prevalence of autism spectrum disorders - Autism and Developmental Disabilities Monitoring Network, United States, 2006

Expression of monocyte chemoattractant protein-1 and macrophage inflammatory protein-1 after focal cerebral ischemia in the rat

Neuroglial activation and neuroinflammation in the brain of patients with autism

Differential monocyte responses to TLR ligands in children with autism spectrum disorders.

Decreased cellular IL-23 but not IL-17 production in children with autism spectrum disorders.

Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome.

Cerebrospinal fluid and serum markers of inflammation in autism.

Elevated cytokine levels in children with autism spectrum disorder.

Immune activation of peripheral blood and mucosal CD3+ lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms.

P304

196-199

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JNEUROIM.2010.10.025

http://www.w3.org/2001/XMLSchema#string

P433

1-2

http://www.w3.org/2001/XMLSchema#string

P478

232

http://www.w3.org/2001/XMLSchema#string

P50

Irva Hertz-Picciotto

P577

2010-11-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49626224

http://www.w3.org/2001/XMLSchema#string

P698

21095018

http://www.w3.org/2001/XMLSchema#string

P921

Autism spectrum

P932

3053074

http://www.w3.org/2001/XMLSchema#string